The intravenous immunoglobulinmarket in the MEA is expected to grow from US$ 497.97 million in 2022 to US$ 711.99 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2022 to 2028.
Rising Prevalence of Immunodeficiency Diseases
Intravenous immunoglobulin (IVIG) is used to treat patients suffering from primary and secondary immunodeficiencies and autoimmune disorders. IVIG is a standard therapy to treat most of the primary immunodeficiencies (PID). The rare genetic diseases can be chronic, weakening, and expensive to treat. Immune Thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by abnormally low levels of platelets; a situation referred to as thrombocytopenia. As per the Rare Diseases Organization, around 200,000 ITP cases are recorded across the region annually. Thus, increasing prevalence of immunodeficiency diseases drives the growth of the intravenous immunoglobulin market.Market Overview
The Middle East & Africa intravenous immunoglobulin market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East & Africa. Saudi Arabia was this region's largest intravenous immunoglobulin market in 2021. The Middle East & Africa intravenous immunoglobulin market is anticipated to grow at a CAGR of 6.1% during the forecast period; this growth can be attributed to the increasing government support for healthcare and the rising awareness regarding IgRT. The increasing prevalence of GBS and infectious diseases drives the intravenous immunoglobulin market in Saudi Arabia. According to the article, Application of intravenous immunoglobulin (IVIg) to modulate inflammation in critical COVID-19," published in the National Library of Medicine (NLM) in 2021, administration of IVIg within a specific dosage was extremely beneficial toward reducing mortality and perhaps even the length of hospitalization of patients exhibiting severe COVID-19 symptoms.Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Intravenous Immunoglobulin Market - By Type
1.3.2 MEA Intravenous Immunoglobulin Market - By Application
1.3.3 MEA Intravenous Immunoglobulin Market - By Distribution Channel
1.3.4 MEA Intravenous Immunoglobulin Market - By End User
1.3.5 MEA Intravenous Immunoglobulin Market - By Country
2. MEA Intravenous Immunoglobulin Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Intravenous Immunoglobulin Market - Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Expert Opinion
5. MEA Intravenous Immunoglobulin Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Immunodeficiency Diseases
5.1.2 Increasing Geriatric Population
5.2 Market Restraints
5.2.1 Adverse Effects of Immunoglobulin Therapy
5.3 Future Trends
5.3.1 Strong Pipeline Candidates for IVIG
5.4 Impact Analysis
6. Intravenous Immunoglobulin Market- MEA Analysis
6.1 MEA Intravenous Immunoglobulin Market Revenue Forecast and Analysis
7. MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028- by Type
7.1 Overview
7.2 MEA Intravenous Immunoglobulin Market, By Type 2022 & 2028 (%)
7.3 IgG
7.3.1 Overview
7.3.2 IgG Revenue and Forecast to 2028 (US$ Million)
7.4 IgM
7.4.1 Overview
7.4.2 IgM - Revenue and Forecast to 2028 (US$ Million)
7.5 IgA
7.5.1 Overview
7.5.2 IgA - Revenue and Forecast to 2028 (US$ Million)
7.6 IgE
7.6.1 Overview
7.6.2 IgE - Revenue and Forecast to 2028 (US$ Million)
7.7 IgD
7.7.1 Overview
7.7.2 IgD - Revenue and Forecast to 2028 (US$ Million)
8. MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by Application
8.1 Overview
8.2 MEA Intravenous Immunoglobulin Market, By Application 2022 & 2028 (%)
8.3 Hypogammaglobulinemia
8.3.1 Overview
8.3.2 Hypogammaglobulinemia - Market Revenue and Forecast to 2028 (US$ Million)
8.4 Chronic Inflammatory Demyelinating Polyneuropathy
8.4.1 Overview
8.4.2 Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases - Market Revenue and Forecast to 2028 (US$ Million)
8.6 Myasthenia Gravis
8.6.1 Overview
8.6.2 Myasthenia Gravis - Market Revenue and Forecast to 2028 (US$ Million)
8.7 Multifocal Motor Neuropathy
8.7.1 Overview
8.7.2 Multifocal Motor Neuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.8 Idiopathic Thrombocytopenic Purpura
8.8.1 Overview
8.8.2 Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecast to 2028 (US$ Million)
8.9 Inflammatory Myopathies
8.9.1 Overview
8.9.2 Inflammatory Myopathies - Market Revenue and Forecast to 2028 (US$ Million)
8.10 Specific Antibody Deficiency
8.10.1 Overview
8.10.2 Specific Antibody Deficiency - Market Revenue and Forecast to 2028 (US$ Million)
8.11 Guillain-Barre Syndrome
8.11.1 Overview
8.11.2 Guillain-Barre Syndrome - Market Revenue and Forecast to 2028 (US$ Million)
8.12 Others
8.12.1 Overview
8.12.2 Others - Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by Distribution Channel
9.1 Overview
9.2 MEA Intravenous Immunoglobulin Market, By Distribution Channel 2022 & 2028 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others - Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by End User
10.1 Overview
10.2 MEA Intravenous Immunoglobulin Market, By End User 2022 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
10.4 Specialty Clinics
10.4.1 Overview
10.4.2 Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others - Market Revenue And Forecasts To 2028 (US$ Million)
11. MEA Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 - Country Analysis
11.1 Overview
11.1.1 Middle East & Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Country (%)
11.1.1.1 Saudi Arabia: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 Overview
11.1.1.1.2 Saudi Arabia Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.1.1.1.4 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.1.1.1.5 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
11.1.1.1.6 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
11.1.1.2 South Africa: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 Overview
11.1.1.2.2 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.1.1.2.4 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.1.1.2.5 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
11.1.1.2.6 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
11.1.1.3 UAE: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 Overview
11.1.1.3.2 UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.1.1.3.4 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.1.1.3.5 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
11.1.1.3.6 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
11.1.1.4 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.4.1 Overview
11.1.1.4.2 Rest of the Middle East and Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.1.1.4.4 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.1.1.4.5 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
11.1.1.4.6 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
12. MEA Intravenous Immunoglobulin Market-Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Takeda Pharmaceutical Company Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Grifols, S.A.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 ADMA Biologics, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio Products Laboratory Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Shanghai RAAS
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Octapharma AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kedrion S.p.A
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CSL Behring (CSL Limited)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Prothya Biosolutions B.V.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms in Intravenous Immunoglobulin Market
List of Tables
Table 1. MEA Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 3. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 4. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 5. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 6. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 7. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 8. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 9. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 10. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 11. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 12. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 13. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 14. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 15. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 16. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 17. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Intravenous Immunoglobulin Market
Table 19. Recent Organic Growth Strategies in the Intravenous Immunoglobulin Market
Table 20. Glossary of Terms in Intravenous Immunoglobulin Market
List of Figures
Figure 1. MEA Intravenous Immunoglobulin Market Segmentation
Figure 2. MEA Intravenous Immunoglobulin Market Segmentation, By Country
Figure 3. MEA Intravenous Immunoglobulin Market Overview
Figure 4. MEA Intravenous Immunoglobulin Market, by Type
Figure 5. MEA Intravenous Immunoglobulin Market, by Country
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Impact Analysis
Figure 8. MEA Intravenous Immunoglobulin Market- Revenue Forecast and Analysis - 2020 - 2028
Figure 9. MEA Intravenous Immunoglobulin Market, by Type 2022 & 2028 (%)
Figure 10. MEA IgG Revenue and Forecasts to 2028 (US$ Million)
Figure 11. MEA IgM - Revenue and Forecasts to 2028 (US$ Million)
Figure 12. MEA IgA - Revenue and Forecasts to 2028 (US$ Million)
Figure 13. MEA IgE - Revenue and Forecasts to 2028 (US$ Million)
Figure 14. MEA IgD - Revenue and Forecasts to 2028 (US$ Million)
Figure 15. MEA Intravenous Immunoglobulin Market, by Application 2022 & 2028 (%)
Figure 16. MEA Hypogammaglobulinemia - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. MEA Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. MEA Immunodeficiency Diseases - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. MEA Myasthenia Gravis - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. MEA Multifocal Motor Neuropathy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. MEA Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. MEA Inflammatory Myopathies - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. MEA Specific Antibody Deficiency - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. MEA Guillain-Barre Syndrome - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. MEA Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. MEA Intravenous Immunoglobulin Market, by Distribution Channel 2022 & 2028 (%)
Figure 27. MEA Hospital Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. MEA Retail Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. MEA Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. MEA Intravenous Immunoglobulin Market, by End User 2022 & 2028 (%)
Figure 31. MEA Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 32. MEA Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 33. MEA Others- Market Revenue And Forecasts To 2028 (US$ Million)
Figure 34. Middle East & Africa Intravenous Immunoglobulin Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 35. Middle East & Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Country (%)
Figure 36. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ADMA Biologics, Inc.
- Bio Products Laboratory Ltd.
- CSL Behring (CSL Limited)
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- Pfizer Inc.
- Prothya Biosolutions B.V.
- Shanghai RAAS
- Takeda Pharmaceutical Company Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 171 |
| Published | December 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 497.97 Million |
| Forecasted Market Value ( USD | $ 711.99 Million |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Africa, Middle East |
